Chronic Schistosoma japonicum Infection Reduces Immune Response to Vaccine against Hepatitis B in Mice

PLoS ONE

Volumn 7, Issue 12, 2012, Pages

  Chen, Lin ^a,b   Liu, Wen qi ^a   Lei, Jia hui ^a   Guan, Fei ^a   Li, Man jun ^a   Song, Wen jian ^b   Li, Yong long ^a   Wang, Ting ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b JIANGHAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; HEPATITIS B ANTIBODY; HEPATITIS B VACCINE; INTERLEUKIN 2; PRAZIQUANTEL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY PRODUCTION; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE SEVERITY; DOWN REGULATION; DRUG EFFICACY; DRUG SAFETY; GENE EXPRESSION PROFILING; HEPATITIS B; IMMUNE RESPONSE; MALE; MIXED INFECTION; MOUSE; NONHUMAN; POLYMERASE CHAIN REACTION; PROTEIN BLOOD LEVEL; SCHISTOSOMIASIS JAPONICA; TH1 CELL; TH2 CELL; TREATMENT DURATION; TREATMENT RESPONSE;

ANIMALS; ANTHELMINTICS; CHRONIC DISEASE; CYTOKINES; HEPATITIS B VACCINES; IMMUNE SYSTEM; INTERFERON-GAMMA; INTERLEUKIN-2; MALE; MICE; MICE, INBRED BALB C; PRAZIQUANTEL; RNA, MESSENGER; SCHISTOSOMA JAPONICUM; SCHISTOSOMIASIS JAPONICA; SPLEEN; TH2 CELLS;

HEPATITIS B VIRUS; JAPONICA; MUS; SCHISTOSOMA; SCHISTOSOMA JAPONICUM;

EID: 84871343795     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0051512     Document Type: Article

References (39)

1. John JJ, Jayabal P, (1972) Oral polio vaccination of children in the tropics. I. The poor seroconversion rates and the absence of viral interference. Am J Epidemiol 96: 263-9.
2. Patriarca PA, Wright PF, Jacob JT, (1991) Factors affecting immunogenicity of oral poliovirus vaccine in developing countries: review. Rev Infect Dis 13: 926-39.
3. Sutter RW, Patriarca PA, Brogan S, (1991) Outbreak of paralytic poliomyelitis in Oman: evidence for widespread transmission among fully vaccinated children. Lancet 338: 715-20.
4. Lanata CF, Black RE, Burton B, Midthun K, Davidson B, (1996) Safety, immunogenicity and efficacy of one and three doses of the tetravalent rhesus rotavirus vaccine in infants in Lima, Peru. J Infect Dis 174: 268-75.
5. Sjogren MH, (2005) Prevention of hepatitis B in nonresponders to initial hepatitis B virus vaccination. Am J Med 118 (Suppl 10A): 34-39.
6. Borkow G, Bentwich Z, (2002) Host background immunity and human immunodeficiency virus protective vaccines, a major consideration for vaccine efficacy in Africa and in developing countries. Clin Diagn Lab Immunol 9: 505-507.
7. Shepard CW, Simard EP, Finelli L, Fiore AE, Bell BP, (2006) Hepatitis B virus infection: epidemiology and vaccination. Epidemiol Rev 28: 112-125.
8. Zanetti AR, Van Damme P, Shouval D, (2008) The global impact of vaccination against hepatitis B: a historical overview. Vaccine 26: 6266-6273.
9. Michel ML, Tiollais P, (2010) Hepatitis B vaccines: protective efficacy and therapeutic potential. Pathol Biol (Paris) 58: 288-295.
10. Wainwright RB, McMahon BJ, Bulkow LR, Hall DB, Fitzgerald MA, et al. (1989) Duration of immunogenicity and efficacy of hepatitis B vaccine in a Yupik Eskimo population. JAMA 261: 2362-2366.
11. Samuel D, Muller R, Alexander G, Fassati L, Ducot B, et al. (1993) Liver transplantation in European patients with the hepatitis B surface antigen. N Engl J Med 329: 1842-1847.
12. Bentwich Z. Kalinkovich A, Weisman Z, Borkow G, Beyers N, et al. (1999) Can eradication of helminthic infections change the face of AIDS and tuberculosis? Immunol Today 20: 485-487.
13. Guan you-gen, Zhu-Ge yi, (2008) The immune efficacy of HBV on antibody negative rural school-age children. Chinese J Child Health Care. l6: 494-495.
14. Zai xiang-jun, (2002) Current review of non-hyporesponsiveness after hepatitis B vaccination. Railway Med J. 30: 63-65.
15. Steinmann P, Keiser J, Bos R, Tanner M, Utzinger J, (2006) Schistosomiasis and water resources development: systematic review, meta-analysis, and estimates of people at risk. Lancet Infect Dis 6: 411-425.
16. King CH, Dickman K, Tisch DJ, (2005) Reassessment of the cost of chronic helmintic infection: a meta-analysis of disability-related outcomes in endemic schistosomiasis. Lancet 365: 1561-1569.
17. Gryseels B, Polman K, Clerinx J, Kestens L, (2006) Human schistosomiasis. Lancet 368: 1106-1118.
18. Sabin EA, M.I Araujo, E.M Carvalho, E.J Pearce, (1996) Impairment of tetanus toxoid-specific Th1-like immune responses in humans infected with Schistosoma mansoni. J. Infect. Dis 173: 269-272.
19. van Riet E, Hartgers FC, Yazdanbakhsh M, (2007) Chronic helminth infections induce immunomodulation: Consequences and mechanisms. Immunobiology 212: 475-490.
20. Wu Guan-ling (chief editor) (2005) Human Parasitology (3rd edition). People's Health Publishing House, Beijing, China. p364.
21. Song Wen-jian, Cheng Yu-li, Liu La-zhen, Komg Zheng, Song HU, et al. (2005) Impact of chronic schistosomiasis japonica on the protective immunity induced by vaccineation against hepatitis B Virus. Chin J Parasitol Parasit Dis 23: 163-165.
22. Elias D, Akuffo H, Pawlowski A, Haile M, Schon T, et al. (2005) Schistosoma mansoni infection reduces the protective efficacy of BCG vaccination against virulent Mycobacterium tuberculosis. Vaccine 23: 1326-1334.
23. Ghaffar YA, Kamel M, Wahab MFA, Dorgham LS, Saleh MS, et al. (1990) Hepatitis B vaccination in children infected with Schistosoma mansoni: correlation with ultrasonographic data. Am J Trop Med Hyg 43: 516-9.
24. Ghaffar YA, Kamel M, El-Sobkv M, Bahnasy R, Strickland GT, (1989) Compromised response to hepatitis B vaccine of neonates born to Egyptian mothers having schistosomiasis. Lancet ii: 272.
25. Collins HL, Kaufmann SH, (2001) The many faces of host responses to tuberculosis. Immunology 103: 1-9.
26. Bundy D, Sher A, Michael E, (2000) Good worms or bad worms: do worm infections affect the epidemiological patterns of other diseases? Parasitol Today 16: 273-274.
27. van Riet E, Hartgers FC, Yazdanbakhsh M, (2007) Chronic helminth infections induce immunomodulation: consequences and mechanisms. Immunobiology 212: 475-490.
28. Sabin EA, Araujo MI, Carvalho EM, Pearce EJ, (1996) Impairment of tetanus toxoid-specific Th1-like immune responses in humans infected with Schistosoma mansoni. J Infect Dis 173: 269-272.
29. Muniz-Junqueira MI, Tavares-Neto J, Prata A, Tosta CE, (1996) Antibody response to Salmonella typhi in human schistosomiasis mansoni. Rev Soc Bras Med Trop 29: 441-445.
30. Borkow G, Bentwich Z, (2006) HIV and helminth co-infection: is deworming necessary? Parasite Immunol 28: 605-612.
31. Bocher WO, Galun E, Marcus H, Daud N, Terkieltaub D, et al. (2000) Reduced hepatitis B virus surface antigen-specific Th1 helper cell frequency of chronic HBV carriers is associated with a failure to produce antigen-specific antibodies in the trimera mouse. Hepatology 31: 480-487.
32. Eren R, Lubin I, Terkieltaub D, Ben-Mosh O, Zauberman EA, et al. (1998) Human monoclonal antibodies specific to hepatitis B virus generated in a human/mouse radiation chimera: the Trimera system. Immunology 93: 154-161.
33. Cooper PJ, Chico ME, Losonsky G, Sandoval C, Espinel I, et al. (2000) Albendazole Treatment of Children with Ascariasis Enhances the Vibriocidal Antibody Response to the Live Attenuated Oral Cholera Vaccine CVD 103-HgR. J Infect Dis 182: 1199-1206.
34. Bentwich Z, Kalinkovich A, Weisman Z, (1995) Immune activation is a dominant factor in the pathogenesis of African AIDS. Immunol Today 16: 187-91.
35. Stewart GR, Boussinesq M, Coulson T, (1999) Onchocerciasis modulates the immune response to mycobacterial antigens. Clin Exp Immunol 117: 517-23.
36. Borkow G, Leng Q, Weisman Z, Stein M, Galai N, et al. (2000) Chronic immune activation associated with intestinal helminth infections results in impaired signal transduction and anergy. J. Clin. Invest 106: 1053-1060.
37. Borkow G &. Bentwich Z, (2006) HIV and helminth co-infection: is deworming necessary? Parasite Immunology 28: 605-612.
38. McClary H, Koch R, Chisari FV, Guidotti LG, (2000) Inhibition of hepatitis B virus replication during schistosoma mansoni infection in transgenic mice. J Exp Med 192: 289-294.
39. Cioli D, Pica-Mattoccia L, (2003) Praziquantel. Parasitol Res 90 (Supp 1): 3-9.